Clinical significance of Y chromosome loss in hematologic disease.
about
Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer PatientsMosaic loss of chromosome Y is associated with common variation near TCL1AMosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer DiseaseNew data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes.Myelodysplastic syndromes: Contemporary review and how we treat.Loss of chromosome Y (LOY) in blood cells is associated with increased risk for disease and mortality in aging men.Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer.Human adipose stromal cells (ASC) for the regeneration of injured cartilage display genetic stability after in vitro culture expansion.The G⁵¹⁶T CYP2B6 germline polymorphism affects the risk of acute myeloid leukemia and is associated with specific chromosomal abnormalitiesRare cytogenetic abnormalities in myelodysplastic syndromes.Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells.Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer.Donor cell leukemia: a critical review.Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.Unraveling the molecular pathophysiology of myelodysplastic syndromes.Initially lymphocytic Sweet's syndrome in male patients with myelodysplasia: a distinguished clinicopathological entity? Case report and systematic review of the literature.I walk the line: how to tell MDS from other bone marrow failure conditions.Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.Successful treatment of myelodysplastic syndrome and chronic hepatitis C using combined peginterferon-α-2b and ribavirin therapy.Loss of Y chromosome in the malignant peripheral nerve sheet tumor of a patient with Neurofibromatosis type 1.Loss of Y-chromosome does not correlate with age at onset of head and neck carcinoma: a case-control study.A case of successful management of HHV-8⁺, EBV⁺ germinotropic lymphoproliferative disorder (GLD).Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases.Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL.Sex chromosome changes in leukemia: cytogenetics and molecular aspects.Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome.Sex chromosome loss may represent a disease-associated clonal population in chronic lymphocytic leukemiaAcute myeloid leukemiaAcute Myeloid Leukemia
P2860
Q28383417-CB8D5849-FF3D-45C8-B81F-657DE87CFA86Q28393244-E756F65F-D0C1-4E91-A205-2C472C345F2DQ28396929-56611BF7-90BC-43A9-B870-229856360DEEQ30995796-404E9520-7F5E-44EB-AE7D-DC3F3B10465DQ33429195-64474B9D-D385-4E70-A029-1E76902089E6Q33639347-D106DDD2-7F41-4ECC-95D1-4C17726C9570Q33750753-EFFF3DD9-570C-447F-A9D9-09C13413EB0DQ34417635-C04DAEED-5A4E-4317-9074-9A896A90A181Q35035762-DB2FE68E-1574-4E66-B887-C1B76424A0D0Q35106387-BD3226C1-7CCE-4F28-B100-8263AC7D4603Q35565387-6EF0A1F2-B344-47CE-B3D3-B417900C7DDDQ35668398-EE51FFF5-073E-422A-BCAE-B128F25C1D7AQ36562102-0C483B39-F30D-4464-929F-3E0D9B888642Q36746425-85E6333A-F9CE-4B5B-8E65-ECD866AA0FBDQ36961721-FB25CC72-54C6-4EEA-8A83-09195EAABC2AQ37671806-8D14B24A-B6B8-4EF2-A1DA-893DC6227429Q38203141-9A14D28E-3602-4CD0-B574-0E7AEC5F628AQ38235622-B65ACBFA-9893-4EE5-8F0D-A71F2F62410AQ38447382-1FD763B0-A5FB-4528-A30D-618E1AA805D4Q38662334-F975EC5F-33AC-4D87-AF8A-A1B268FD1EB4Q39316000-227FC7B9-2F8F-46E0-9B4C-2DC58C6E7C61Q40164494-6DA84ADE-3284-4822-B371-2B8719065511Q41832916-A3D454A4-758C-4F8F-A12F-3EA525CE42EBQ43632604-F77E298D-232E-4C6A-8B10-3DC1CF936380Q44804346-2AC4739C-2E9A-4FD6-9D64-E473E39ECC0EQ46947501-77E22979-E001-4D31-8FAC-746055BD7EA1Q47693182-8D47B1D9-1B3F-44D9-8DCE-B2764029A77FQ48186139-3D931CF6-FDF4-4116-89BC-BD0692C1D14CQ54222794-FA44AB6D-BE6E-48CA-8277-8C51A7E17517Q58041700-0DF6952E-C62C-4569-B995-B7E88B4AA7A9Q58481761-C2440A42-74D1-454A-9DCA-D344A59049DEQ58481811-9CFC4922-E16A-4DBB-8E95-703E5A96A2AC
P2860
Clinical significance of Y chromosome loss in hematologic disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clinical significance of Y chromosome loss in hematologic disease.
@ast
Clinical significance of Y chromosome loss in hematologic disease.
@en
type
label
Clinical significance of Y chromosome loss in hematologic disease.
@ast
Clinical significance of Y chromosome loss in hematologic disease.
@en
prefLabel
Clinical significance of Y chromosome loss in hematologic disease.
@ast
Clinical significance of Y chromosome loss in hematologic disease.
@en
P2093
P1476
Clinical significance of Y chromosome loss in hematologic disease.
@en
P2093
Rybicki BA
Van Dyke DL
P356
10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I
P577
2000-01-01T00:00:00Z